PyInvesting

Market research

102460.KO REYON Pharmaceutical Co., Ltd

KO KRW Healthcare

Latest close

9,320.00 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
170B
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
0.48

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

REYON Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 188.0% above its 200 day moving average.

From a valuation standpoint, the stock is 74.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.

REYON Pharmaceutical Co., Ltd's total revenue rose by 0.9% to $33B since the same quarter in the previous year.

Its net income has increased by 251.1% to $2B since the same quarter in the previous year.

Finally, its free cash flow fell by 90.8% to $-16B since the same quarter in the previous year.

Based on the above factors, REYON Pharmaceutical Co., Ltd gets an overall score of 4/5.